A novel CCK2/gastrin receptor-localizing radiolabeled peptide probe for personalized diagnosis and therapy of patients with progressive or metastatic medullary thyroid carcinoma – GRAN-T-MTC – a multicenter phase I study
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.